コンテンツへスキップ
Merck

EQCYTMAG-93K

MILLIPLEX® Equine Cytokine/Chemokine Panel

Configurable Equine Cyokine/Chemokine 23-Plex Panel

別名:

Equine cytokine panel, Luminex equine cytokine multiplex kit, Millipore horse cytokine kit, horse inflammation assay

ログインで組織・契約価格をご覧ください。

この商品について

UNSPSC Code:
12161503
NACRES:
NA.47
eCl@ss:
32161000


製品名

MILLIPLEX® Equine Cytokine/Chemokine Panel,

Quality Level

description

Configurable Equine Cyokine/Chemokine 23-Plex Panel

species reactivity

horse

packaging

pkg of 1 ea

manufacturer/tradename

Milliplex®

assay range

sensitivity: 16.3 pg/mL
(FGF-2), sensitivity: 16.7 pg/mL
(IP-10), sensitivity: 165 pg/mL
(IFNγ), sensitivity: 25.3 pg/mL
(IL-18), sensitivity: 29.3 pg/mL
(IL-1β), sensitivity: 3.9 pg/mL
(RANTES/CCL5), sensitivity: 3.94 pg/mL
(GM-CSF), sensitivity: 340 pg/mL
(G-CSF), sensitivity: 355 pg/mL
(IL-4), sensitivity: 39-130 pg/mL
(IL-13), sensitivity: 39.1 pg/mL
(IL-1α), sensitivity: 399 ng/mL
(MCP-1), sensitivity: 457 pg/mL
(Fractalkine/CS3CL1), sensitivity: 49.2 pg/mL
(IL-12 (p70)), sensitivity: 5.2 pg/mL
(TNFα), sensitivity: 62.5 pg/mL
(IL-10), sensitivity: 7.8 pg/mL
(GRO), sensitivity: 74.3 pg/mL
(IL-8/CXCL8), sensitivity: 8.3 pg/mL
(Eotaxin/CCL11), standard curve range: 15-15,000 pg/mL
(IL-17A), standard curve range: 15-15,000 pg/mL
(IL-2), standard curve range: 15-15,000 pg/mL
(IL-5), standard curve range: 15-15,000 pg/mL
(IL-6), standard curve range: 15-15,000 pg/mL
(IP-10), standard curve range: 29-30,000 pg/mL
(IL-1β), standard curve range: 293-300,000 pg/mL
(IL-4), standard curve range: 34-35,000 pg/mL
(IL-18), standard curve range: 342-350,000 ng/mL
(MCP-1), standard curve range: 39-40,000 pg/mL
(IL-12 (p70)), standard curve range: 39-40,000 pg/mL
(IL-13), standard curve range: 4-4,000 pg/mL
(TNFα), standard curve range: 488-500,000 pg/mL
(IFNγ), standard curve range: 49-50,000 pg/mL
(IL-10), standard curve range: 5-5,000 pg/mL
(GM-CSF), standard curve range: 5-5,000 pg/mL
(RANTES/CCL5), standard curve range: 59-60,000 pg/mL
(IL-1α), standard curve range: 59-60,000 pg/mL
(IL-8/CXCL8), standard curve range: 6-6,000 pg/mL
(GRO), accuracy: 74%
(IL-17a), accuracy: 76%
(IL-6), accuracy: 78%
(FGF-2), accuracy: 82%
(G-CSF), accuracy: 83%
(IFNγ), accuracy: 83%
(IL-12 (p70)), accuracy: 85%
(IL-13), accuracy: 86%
(IL-10), accuracy: 88%
(RANTES/CCL5), accuracy: 89%
(IL-8/CXCL8), accuracy: 90%
(IL-2), accuracy: 90%
(MCP-1), accuracy: 91%
(Fractalkine/CS3CL1), accuracy: 92%
(IL-5), accuracy: 93%
(Eotaxin/CCL11), accuracy: 97%
(GRO), sensitivity: 1.4 pg/mL
(IL-6), sensitivity: 10.6 pg/mL
(IL-5), sensitivity: 13.5 pg/mL
(IL-2), sensitivity: 15.4 pg/mL
(IL-17A)

technique(s)

multiplexing: suitable

input

plasma
cell culture supernatant(s)

detection method

fluorometric (Luminex® xMAP® technology)

shipped in

wet ice

storage temp.

2-8°C

General description

Researching horse cytokines and chemokines is pivotal for advancing our understanding of equine immunology and the underlying mechanisms of various diseases. By investigating the roles and interactions of these signaling molecules, scientists can uncover critical insights into inflammatory processes, immune responses, and the pathophysiology of equine conditions. This knowledge not only enhances our fundamental understanding of equine biology but also drives the development of targeted therapeutic strategies and interventions in equine medicine.

Application

MILLIPLEX® Qualified assays undergo rigorous assay development, verification, and Quality Control testing to achieve optimal performance. Simultaneously analyze up to 23 analytes in equine serum, plasma, and cell culture supernatants.

Analytes included: Eotaxin/CCL11, FGF-2, Fractalkine/CX3CL1, G-CSF, GM-CSF, GRO/KC, IFN-γ, IL-1α, IL-1β, IL-2, IL-4, IL-5, IL-6, IL-8, IL-10, IL-12 (p70), IL-13, IL-17A, IL-18, IP-10 (CXCL10), MCP-1, RANTES (CCL5), TNF-α

Assay Characteristics: Refer to kit protocol for assay cross-reactivity, sensitivity, precision, and accuracy.

Features and Benefits

  • Comprehensive 23-plex Cytokine and Chemokine Panel: Simultaneously quantify 23 critical immune mediators (including Eotaxin, FGF-2, G-CSF, IL-1α, IL-6, IL-10, TNFα, and more) in equine serum, plasma, or culture supernatant samples, providing a holistic view of the equine immune response.
  • High-Throughput 96-well Format: Analyze up to 38 samples in duplicate, maximizing laboratory efficiency and sample utilization while minimizing reagent costs and hands-on time.
  • In-Depth Immune Profiling: Investigate the immune response in equine models of infectious diseases, osteoarthritis, respiratory diseases, and other conditions, facilitating a better understanding of disease mechanisms and potential therapeutic targets.
  • Enhanced Statistical Power: Generate multi-parameter datasets from individual samples, improving experimental design and enabling sophisticated statistical analyses for publication-quality research outcomes.

Legal Information

Luminex is a registered trademark of Luminex Corporation
MILLIPLEX is a registered trademark of Merck KGaA, Darmstadt, Germany
xMAP is a registered trademark of Luminex Corp

Disclaimer

For research use only. Not for use in diagnostic procedures.

Label License/Sticker for Assay Product:

By opening the packaging containing this Assay Product (which contains fluorescently labeled microsphere beads authorized by Luminex Corporation) or using this Assay Product in any manner, you are consenting and agreeing to be bound by the End User Terms and Conditions and the End User License Agreement available at http://support.diasorin.com/end-user-terms-and-conditions/. If you do not agree to all of the terms and conditions, you must promptly return this Assay Product for a full refund prior to using it in any manner.


Still not finding the right product?

Explore all of our products under


signalword

Danger

target_organs

Respiratory Tract

保管分類

10 - Combustible liquids

wgk

WGK 3

Hazard Classifications

Acute Tox. 4 Dermal - Acute Tox. 4 Inhalation - Acute Tox. 4 Oral - Aquatic Chronic 3 - Eye Dam. 1 - STOT RE 2


適用法令

試験研究用途を考慮した関連法令を主に挙げております。化学物質以外については、一部の情報のみ提供しています。 製品を安全かつ合法的に使用することは、使用者の義務です。最新情報により修正される場合があります。WEBの反映には時間を要することがあるため、適宜SDSをご参照ください。

Please refer to KIT Component information

pdsc

Please refer to KIT Component information

prtr

Please refer to KIT Component information

fsl

Please refer to KIT Component information

ishl_indicated

Please refer to KIT Component information

ishl_notified

Please refer to KIT Component information

cart

キットコンポーネントの情報を参照してください

jan



試験成績書(COA)

製品のロット番号・バッチ番号を入力して、試験成績書(COA) を検索できます。ロット番号・バッチ番号は、製品ラベルに「Lot」または「Batch」に続いて記載されています。

以前この製品を購入いただいたことがある場合

文書ライブラリで、最近購入した製品の文書を検索できます。

文書ライブラリにアクセスする


関連コンテンツ

Discover the benefits of MILLIPLEX® multiplex assays, based on Luminex® xMAP® multiplex assay technology, that provide consistent, high-quality results and see how these multiplex biomarker Luminex® assays are being used to advance research.

Discover benefits of using biomarker detection multiplex immunoassays for companion and agricultural animal health research and find vet med multiplex assays.

一貫した高品質の結果をもたらすLuminex® xMAP®マルチプレックスアッセイテクノロジーに基づくMILLIPLEX® マルチプレックスアッセイの利点をご確認ください。そしてマルチプレックスバイオマーカーLuminex® アッセイが研究の発展にどのように活用されているのかをご覧ください。

すべての関連コンテンツを見る